Relationship Between Red Cell Distribution Width (RDW) and HbA1C in Patients With Type 2 Diabetes Mellitus After Glycemic Control

Recruiting now

Conditions studied: Type 2 Diabetes

In brief

Diabetes mellitus (DM) is an epidemic disease, with approximately 463 million persons diagnosed with it. Of those, 90% are patients with type 2 DM (T2DM). Some estimates indicate that 700 million cases of DM will be reported in 2045. T2DM develops due to insulin resistance, leading to reduced insulin secretion. DM has a number of associated complications, such as nephropathy, neuropathy, and cardiovascular disease.

Key facts

Study ID

NCT06067399

Run by

New Valley University

People needed

250

Starts

2026-05-01

Expected to finish

2028-06-30

Last updated by the study team

2026-07-30

Who can join

Age: 40 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Patients diagnosed to have Uncontrolled type 2 diabetes mellitus (HbA1C more than 7%)

You may not qualify if…

• Patients diagnosed to have type 1 diabetes.
• Patients are diagnosed to have secondary diabetes.
• Clinical states associated with increased RDW:
• Anemia (Female Hb less than 12, Male Hb less than 13) either due to hemolysis, or in response to ineffective red cell production, which can be caused by deficiencies in iron, vitamin B12 or folate.
• After blood transfusions
• Pregnancy, thrombotic thrombocytopenic purpura and inflammatory bowel disease.

Where it is running

• New Valley University- Faculty of Medicine — Al Khārjah, Egypt (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.